Management and Senior Staff

Dr. Subhash Kapre
Chief Executive Officer

Dr. Subhash Kapre established Inventprise in 2012. He brings with him forty-five years of extensive scientific and commercial expertise from his work leading R&D and business development at the Serum Institute of India. He is known internationally for his wide-ranging R&D expertise in bacterial and viral vaccines, bio-therapeutics such as therapeutic monoclonal antibodies, and biopharmaceuticals. Dr. Kapre also has expertise in the establishment of WHO-accredited large-scale vaccine manufacturing plants, capable of supplying doses in the hundreds of millions. Dr. Kapre’s contributions have resulted in him being awarded over 50 patents and he has published numerous scientific papers.

Yves Leurquin
Co-Chief Executive Officer

Yves brings over 30 years of Vaccines leadership experience in Market Access, Sales and Government Affairs with a proven track record in developed and developing countries, supranational and public tender business. Prior to his current position, he worked for the largest Japanese pharmaceutical company Takeda as Regional Head for Europe & Canada, and Global Head Vaccine Pricing focusing on the development and global launch preparation of a Dengue vaccine. Before that, Yves worked for Janssen as Executive Vice President International and Government Affairs. During his tenure at Janssen, Yves led the Marketing and Sales functions and was responsible for Latin America, Asia, Africa and International Organizations. He also developed and launched with WHO a new vaccine winning US $1bn contracts with UNICEF and PAHO. Before joining Janssen, Yves was heading the Middle East and Africa region for GSK Vaccines.

Pradip Ghate
Chief Operating Officer

Mr. Ghate has been in executive management for over thirty-five years, with special expertise in aseptic sterile operations for biological and pharmaceutical products. Having worked in key positions at Cardinal Health and Catalent Pharmaceuticals, his operations experience ranges from formulation to finish & packaging and quality assurance.

Dave Goesling
Chief Financial Officer

Dave brings to Inventprise over 35 years of financial and accounting experience, including the past 15 years in the life sciences sector with a clinical stage biotech and a commercial stage medical device firm. Dave has extensive experience in all areas of financial management of emerging growth companies, including capital raising events/IPOs, SEC reporting and compliance, M&A, investor relations, international operations, and management of accounting functions. Dave holds a BA in Accounting, an MBA in Finance and achieved a CPA designation (currently inactive).

Dr. Ivan Olave
Director, Viral Vaccines

Ivan has more than 20 years of experience as biochemist with thorough understanding of vaccine development, small drug development, target selection and validation, pre-clinical studies, protein biochemistry and gene regulation. He is skillful in management of projects and personnel, and technology assessment and licensing. Ivan received a Ph.D. in Biochemistry from Rutgers University in New Jersey, and did post-doctoral work at Stanford University in California.

Dr. Anup Datta
Director, Bacterial Vaccines
Dr. Anup is an accomplished professional with 20 years of comprehensive experience in bacterial and protein – subunit vaccines, development and technology transfer from concept to clinical thru licensure and commercial manufacturing. Dr. Anup is recognized as an industry leader in conjugate vaccine development, and played a pivotal leadership role, as a co-inventor and developer of several conjugate vaccines. His broad experience comprises of process & analytical chemistry, biochemistry, including bioconjugation, quality and CMC regulatory. He holds a PhD in the field of polysaccharide conjugate vaccine and has also worked on several NIH/USA funded projects as principal/co-investigator. Dr. Anup has experience working at various senior management level position in the US as well as India, having worked in several premier WHO pre-qualified vaccine development and manufacturing companies.

Ramesh Shanbhag
Director, Facilities and Q.A.
Ramesh has over 30 years of extensive experience in designing and implementing, facility and engineering projects in the pharmaceutical and biotech industry. He has successfully executed projects in 33 countries complying with USFDA, WHO and EU QUALITY & GMP regulations. He has experience in leading  multidisciplinary multi-nationality project teams for successfull execution of projects. He has a Professional Engineer (PE) certification from the U.S., and a Chartered Engineer(CEng) certification from the European Union.

Consultants and advisors


Thomas Monath



Luis Barreto


Mark Kane


Joseph E. Martinez